BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:19 PM
 | 
Apr 22, 2010
 |  BC Extra  |  Clinical News

Pfizer ends study of Sutent for HCC

Pfizer Inc. (NYSE:PFE) said late Thursday that it discontinued the open-label Phase III SUN 1170 trial after a review by the study's IDMC showed that Sutent sunitinib did not meet the...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >